• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

.的临床和环境分离株的抗菌药敏性及毒力基因

Antimicrobial susceptibility and virulence genes of clinical and environmental isolates of .

作者信息

Liew Siew Mun, Rajasekaram Ganeswrei, Puthucheary Sd Ampalam, Chua Kek Heng

机构信息

Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Department of Pathology, Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia.

出版信息

PeerJ. 2019 Jan 22;7:e6217. doi: 10.7717/peerj.6217. eCollection 2019.

DOI:10.7717/peerj.6217
PMID:30697478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6346980/
Abstract

BACKGROUND

is ubiquitous, has intrinsic antibiotic resistance mechanisms, and is associated with serious hospital-associated infections. It has evolved from being a burn wound infection into a major nosocomial threat. In this study, we compared and correlated the antimicrobial resistance, virulence traits and clonal relatedness between clinical and fresh water environmental isolates of .

METHODS

219 isolates were studied: (a) 105 clinical isolates from 1977 to 1985 ( = 52) and 2015 ( = 53), and (b) 114 environmental isolates from different fresh water sources. All isolates were subjected to ERIC-PCR typing, antimicrobial susceptibility testing and virulence factor genes screening.

RESULTS

Clinical and environmental isolates of were genetically heterogenous, with only four clinical isolates showing 100% identical ERIC-PCR patterns to seven environmental isolates. Most of the clinical and environmental isolates were sensitive to almost all of the antipseudomonal drugs, except for ticarcillin/clavulanic acid. Increased resistant isolates was seen in 2015 compared to that of the archived isolates; four MDR strains were detected and all were retrieved in 2015. All clinical isolates retrieved from 1977 to 1985 were susceptible to ceftazidime and ciprofloxacin; but in comparison, the clinical isolates recovered in 2015 exhibited 9.4% resistance to ceftazidime and 5.7% to ciprofloxacin; a rise in resistance to imipenem (3.8% to 7.5%), piperacillin (9.6% to 11.3%) and amikacin (1.9% to 5.7%) and a slight drop in resistance rates to piperacillin/tazobactam (7.7% to 7.5%), ticarcillin/clavulanic acid (19.2% to 18.9%), meropenem (15.4% to 7.5%), doripenem (11.5% to 7.5%), gentamicin (7.7% to 7.5%) and netilmicin (7.7% to 7.5%). Environmental isolates were resistant to piperacillin/tazobactam (1.8%), ciprofloxacin (1.8%), piperacillin (4.4%) and carbapenems (doripenem 11.4%, meropenem 8.8% and imipenem 2.6%). Both clinical and environmental isolates showed high prevalence of virulence factor genes, but none were detected in 10 (9.5%) clinical and 18 (15.8%) environmental isolates. The gene was not detected in any of the clinical isolates. Resistance to carbapenems (meropenem, doripenem and imipenem), β-lactamase inhibitors (ticarcillin/clavulanic acid and piperacillin/tazobactam), piperacillin, ceftazidime and ciprofloxacin was observed in some of the isolates without virulence factor genes. Five virulence-negative isolates were susceptible to all of the antimicrobials. Only one MDR strain harbored none of the virulence factor genes.

CONCLUSION

Over a period of 30 years, a rise in antipseudomonal drug resistance particularly to ceftazidime and ciprofloxacin was observed in two hospitals in Malaysia. The occurrence of resistant environmental isolates from densely populated areas is relevant and gives rise to collective anxiety to the community at large

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3d/6346980/f71b6b7fdaf9/peerj-07-6217-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3d/6346980/2b92a7365730/peerj-07-6217-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3d/6346980/836e1d1e6b40/peerj-07-6217-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3d/6346980/68bf2e7dfde2/peerj-07-6217-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3d/6346980/076bc947fad9/peerj-07-6217-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3d/6346980/f71b6b7fdaf9/peerj-07-6217-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3d/6346980/2b92a7365730/peerj-07-6217-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3d/6346980/836e1d1e6b40/peerj-07-6217-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3d/6346980/68bf2e7dfde2/peerj-07-6217-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3d/6346980/076bc947fad9/peerj-07-6217-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3d/6346980/f71b6b7fdaf9/peerj-07-6217-g005.jpg
摘要

背景

[细菌名称]广泛存在,具有内在的抗生素耐药机制,且与严重的医院感染相关。它已从烧伤创面感染演变成主要的医院内威胁。在本研究中,我们比较并关联了[细菌名称]临床分离株和淡水环境分离株之间的抗菌药物耐药性、毒力特征及克隆相关性。

方法

对219株[细菌名称]分离株进行了研究:(a) 1977年至1985年(n = 52)及2015年(n =  53)的105株临床分离株,以及(b) 来自不同淡水水源的114株环境分离株。所有分离株均进行ERIC-PCR分型、抗菌药物敏感性测试及毒力因子基因筛查。

结果

[细菌名称]的临床和环境分离株在基因上具有异质性,仅有4株临床分离株与7株环境分离株呈现100%相同的ERIC-PCR图谱。大多数临床和环境分离株对几乎所有抗假单胞菌药物敏感,除替卡西林/克拉维酸外。与存档分离株相比,2015年耐药分离株有所增加;检测到4株多重耐药菌株,均于2015年获得。1977年至1985年获得的所有临床分离株对头孢他啶和环丙沙星敏感;但相比之下,2015年获得的临床分离株对头孢他啶的耐药率为9.4%,对环丙沙星的耐药率为5.7%;对亚胺培南(从3.8%升至7.5%)、哌拉西林(从9.6%升至11.3%)和阿米卡星(从1.9%升至5.7%)的耐药性有所上升,对哌拉西林/他唑巴坦(从7.7%降至7.5%)、替卡西林/克拉维酸(从19.2%降至18.9%)、美罗培南(从15.4%降至7.5%)、多利培南(从11.5%降至7.5%)、庆大霉素(从7.7%降至7.5%)和奈替米星(从7.7%降至7.5%)的耐药率略有下降。环境分离株对哌拉西林/他唑巴坦(1.8%)、环丙沙星(1.8%)、哌拉西林(4.4%)和碳青霉烯类药物(多利培南11.4%、美罗培南8.8%、亚胺培南2.6%)耐药。临床和环境分离株均显示毒力因子基因的高流行率,但在10株(9.5%)临床分离株和18株(15.8%)环境分离株中未检测到毒力因子基因。在任何临床分离株中均未检测到[特定基因名称]基因。在一些无毒力因子基因的分离株中观察到对碳青霉烯类药物(美罗培南、多利培南和亚胺培南)、β-内酰胺酶抑制剂(替卡西林/克拉维酸和哌拉西林/他唑巴坦)、哌拉西林、头孢他啶和环丙沙星的耐药性。5株无毒力分离株对所有抗菌药物敏感。仅1株多重耐药菌株未携带任何毒力因子基因。

结论

在30年期间,马来西亚两家医院中对抗假单胞菌药物尤其是对头孢他啶和环丙沙星的耐药性有所上升。来自人口密集地区的耐药环境分离株的出现具有相关性,并引起了整个社区的集体焦虑。

相似文献

1
Antimicrobial susceptibility and virulence genes of clinical and environmental isolates of ..的临床和环境分离株的抗菌药敏性及毒力基因
PeerJ. 2019 Jan 22;7:e6217. doi: 10.7717/peerj.6217. eCollection 2019.
2
Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.来自伊朗北部戈尔甘的铜绿假单胞菌临床分离株的抗菌耐药性、毒力因子和基因型。
Int Microbiol. 2022 Nov;25(4):709-721. doi: 10.1007/s10123-022-00256-7. Epub 2022 Jun 14.
3
Presence of T3SS (exoS, exoT, exoU and exoY), susceptibility pattern and MIC of MDR-Pseudomonas aeruginosa from burn wounds.烧伤创面耐多药铜绿假单胞菌 T3SS(exoS、exoT、exoU 和 exoY)的存在、药敏模式及 MIC。
J Infect Dev Ctries. 2023 Aug 31;17(8):1130-1137. doi: 10.3855/jidc.17580.
4
Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).广谱β-内酰胺类药物对铜绿假单胞菌活性的地理差异:全球SENTRY抗菌药物监测计划(1997 - 2000年)总结
Diagn Microbiol Infect Dis. 2002 Jul;43(3):239-43. doi: 10.1016/s0732-8893(02)00390-5.
5
Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agents.日本铜绿假单胞菌临床分离株对多利培南和其他抗假单胞菌药物的敏感性。
Int J Antimicrob Agents. 2009 Dec;34(6):523-8. doi: 10.1016/j.ijantimicag.2009.07.008. Epub 2009 Sep 12.
6
[Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].[铜绿假单胞菌医院分离株中PER-1型β-内酰胺酶频率及抗菌药物耐药率的调查]
Mikrobiyol Bul. 2012 Jan;46(1):1-8.
7
Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.头孢洛扎/他唑巴坦对澳大利亚血流感染分离的铜绿假单胞菌的活性。
Pathology. 2018 Dec;50(7):748-752. doi: 10.1016/j.pathol.2018.08.009. Epub 2018 Nov 2.
8
[Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].[医院革兰氏阴性病原菌的抗菌药敏模式:哈杰泰佩大学成人医院MYSTIC研究结果(2000 - 2004年)]
Mikrobiyol Bul. 2006 Jul;40(3):147-54.
9
Antimicrobial resistance and genomic rep-PCR fingerprints of Pseudomonas aeruginosa strains from animals on the background of the global population structure.在全球种群结构背景下动物源铜绿假单胞菌菌株的抗菌药物耐药性及基因组重复序列聚合酶链反应指纹图谱
BMC Vet Res. 2017 Feb 21;13(1):58. doi: 10.1186/s12917-017-0977-8.
10
Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.1998年至2001年美国住院患者铜绿假单胞菌和鲍曼不动杆菌临床分离株的抗菌药物敏感性监测。
Antimicrob Agents Chemother. 2003 May;47(5):1681-8. doi: 10.1128/AAC.47.5.1681-1688.2003.

引用本文的文献

1
Co-culture of Helicobacter pylori with oral microorganisms in human saliva.幽门螺杆菌与人唾液中的口腔微生物共培养。
Clin Oral Investig. 2025 Jan 24;29(1):79. doi: 10.1007/s00784-025-06160-4.
2
Comparing antibiotic resistance and virulence profiles of , , and from environmental and clinical settings.比较来自环境和临床环境的[具体细菌名称1]、[具体细菌名称2]和[具体细菌名称3]的抗生素耐药性和毒力特征。 (原文中细菌名称缺失,这里用[具体细菌名称X]表示)
Heliyon. 2024 Apr 26;10(9):e30215. doi: 10.1016/j.heliyon.2024.e30215. eCollection 2024 May 15.
3
Chitosan-Aspirin Combination Inhibits Quorum-Sensing Synthases ( and ) in .

本文引用的文献

1
Prevalence and antibiotic resistance of Pseudomonas aeruginosa in water samples in central Italy and molecular characterization of oprD in imipenem resistant isolates.意大利中部水样中铜绿假单胞菌的流行情况和耐药性以及耐亚胺培南分离株中 oprD 的分子特征。
PLoS One. 2017 Dec 6;12(12):e0189172. doi: 10.1371/journal.pone.0189172. eCollection 2017.
2
Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.多重耐药菌引发疾病过程中抗生素耐药性与毒力之间的相互作用
J Infect Dis. 2017 Feb 15;215(suppl_1):S9-S17. doi: 10.1093/infdis/jiw402.
3
Virulence genome analysis of VRFPA10 recovered from patient with scleritis.
壳聚糖-阿司匹林组合抑制金黄色葡萄球菌中的群体感应合酶(和)。
Life (Basel). 2024 Apr 5;14(4):481. doi: 10.3390/life14040481.
4
Evaluating the In Vivo Virulence of Environmental Using Microinjection Model of Zebrafish ().使用斑马鱼显微注射模型评估环境因素的体内毒力()。 你提供的原文似乎不完整,括号里内容缺失,翻译可能会存在一定局限性。
Antibiotics (Basel). 2023 Dec 15;12(12):1740. doi: 10.3390/antibiotics12121740.
5
Introduce a novel post-biotic against Pseudomonas aeruginosa biofilm formation using Escherchia coli Nissle1917 outer membrane vesicles.利用大肠杆菌 Nissle1917 外膜囊泡介绍一种针对铜绿假单胞菌生物膜形成的新型后生抗生素。
BMC Res Notes. 2023 Sep 9;16(1):201. doi: 10.1186/s13104-023-06504-x.
6
Chlorhexidine Resistance or Cross-Resistance, That Is the Question.洗必泰耐药性或交叉耐药性,这才是问题所在。
Antibiotics (Basel). 2023 Apr 22;12(5):798. doi: 10.3390/antibiotics12050798.
7
Relationship between Biofilm-Formation, Phenotypic Virulence Factors and Antibiotic Resistance in Environmental Pseudomonas aeruginosa.环境中铜绿假单胞菌生物膜形成、表型毒力因子与抗生素耐药性之间的关系
Pathogens. 2022 Sep 5;11(9):1015. doi: 10.3390/pathogens11091015.
8
Clinical Specimens are the Pool of Multidrug- resistant Pseudomonas aeruginosa Harbouring oprL and toxA Virulence Genes: Findings from a Tertiary Hospital of Nepal.临床标本是携带oprL和toxA毒力基因的多重耐药铜绿假单胞菌的来源:尼泊尔一家三级医院的研究结果
Emerg Med Int. 2021 Oct 29;2021:4120697. doi: 10.1155/2021/4120697. eCollection 2021.
9
Proteomic profiling of clinical and environmental strains of Pseudomonas aeruginosa.临床和环境铜绿假单胞菌的蛋白质组学分析。
Mol Biol Rep. 2021 Mar;48(3):2325-2333. doi: 10.1007/s11033-021-06262-8. Epub 2021 Mar 16.
10
Prevalence of the Genes Associated with Biofilm and Toxins Synthesis amongst the Clinical Strains.临床菌株中与生物膜和毒素合成相关基因的流行情况。
Antibiotics (Basel). 2021 Feb 28;10(3):241. doi: 10.3390/antibiotics10030241.
从巩膜炎患者中分离出的VRFPA10的毒力基因组分析。
Genom Data. 2017 Feb 6;12:1-3. doi: 10.1016/j.gdata.2017.02.007. eCollection 2017 Jun.
4
Antibiotic Resistance Patterns of Pseudomonas spp. Isolated from the River Danube.从多瑙河分离出的假单胞菌属的抗生素耐药模式。
Front Microbiol. 2016 May 3;7:586. doi: 10.3389/fmicb.2016.00586. eCollection 2016.
5
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections.铜绿假单胞菌在囊性纤维化慢性肺部感染中的进化适应与多样化
Trends Microbiol. 2016 May;24(5):327-337. doi: 10.1016/j.tim.2016.01.008. Epub 2016 Mar 3.
6
GelJ--a tool for analyzing DNA fingerprint gel images.GelJ——一种用于分析DNA指纹凝胶图像的工具。
BMC Bioinformatics. 2015 Aug 26;16:270. doi: 10.1186/s12859-015-0703-0.
7
Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.铜绿假单胞菌和鲍曼不动杆菌中新兴的广谱耐药性:机制与流行病学。
Int J Antimicrob Agents. 2015 Jun;45(6):568-85. doi: 10.1016/j.ijantimicag.2015.03.001. Epub 2015 Mar 24.
8
Public health need versus sales of antibacterial agents active against multidrug-resistant bacteria: a historical perspective.公共卫生需求与针对多重耐药菌的抗菌药物销售情况:历史视角
J Antimicrob Chemother. 2014 Apr;69(4):1151-3. doi: 10.1093/jac/dkt478. Epub 2013 Dec 16.
9
New antibiotics for bad bugs: where are we?新型抗生素应对耐药菌:进展如何?
Ann Clin Microbiol Antimicrob. 2013 Aug 28;12:22. doi: 10.1186/1476-0711-12-22.
10
Pathogenic potential and genetic diversity of environmental and clinical isolates of Pseudomonas aeruginosa.铜绿假单胞菌的环境和临床分离株的致病潜力和遗传多样性。
APMIS. 2014 Feb;122(2):92-100. doi: 10.1111/apm.12112. Epub 2013 Jul 24.